IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SANJEEV K MITTAL

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1689603102
CMS profile
302907
Location
MEMPHIS, TN

General Payments · PY2018–2024

$8,667.37

  • Reported across 452 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,090.08

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology TN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $968.56 42
Education $121.52 9

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $193.03 9
NOVARTIS PHARMACEUTICALS CORPORATION $118.95 4
Ardelyx, Inc. $117.92 4
Fresenius USA Marketing, Inc. $110.09 5
Retrophin, Inc. $102.06 7
OPKO Pharmaceuticals, LLC $79.90 4
Bayer HealthCare Pharmaceuticals Inc. $71.98 4
CALLIDITAS THERAPEUTICS US INC. $69.60 3
Lilly USA, LLC $64.45 3
Aurinia Pharma U.S., Inc. $54.97 2
Relypsa, Inc. $35.13 2
Acerta Pharma LLC $31.30 2
Boehringer Ingelheim Pharmaceuticals, Inc. $20.70 1
Ultragenyx Pharmaceutical Inc. $20.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $966.30 58
PY2019 $1,159.23 73
PY2020 $747.18 43
PY2021 $1,294.22 74
PY2022 $1,972.13 91
PY2023 $1,438.23 62
PY2024 $1,090.08 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ardelyx, Inc. $29.08 02/13/2024 Food and Beverage Undisputed 01/23/2026 1146696074 CMS
Ardelyx, Inc. $32.50 06/10/2024 Food and Beverage Undisputed 01/23/2026 1146696076 CMS
Ardelyx, Inc. $28.43 08/20/2024 Food and Beverage Undisputed 01/23/2026 1146696078 CMS
Ardelyx, Inc. $27.91 12/18/2024 Food and Beverage Undisputed 01/23/2026 1146696080 CMS
AstraZeneca Pharmaceuticals LP $18.03 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105428260 CMS
AstraZeneca Pharmaceuticals LP $13.27 05/30/2024 Food and Beverage Undisputed 01/23/2026 1104370929 CMS
Aurinia Pharma U.S., Inc. $25.78 04/16/2024 Food and Beverage Undisputed 01/23/2026 1150687651 CMS
Aurinia Pharma U.S., Inc. $29.19 05/06/2024 Food and Beverage Undisputed 01/23/2026 1150687653 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.14 02/13/2024 Food and Beverage Undisputed 01/23/2026 1086262090 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.24 05/20/2024 Food and Beverage Undisputed 01/23/2026 1086269622 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.69 11/05/2024 Food and Beverage Undisputed 01/23/2026 1086140901 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.91 11/20/2024 Food and Beverage Undisputed 01/23/2026 1086189490 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.70 08/14/2024 Food and Beverage Undisputed 01/23/2026 1118110785 CMS
CALLIDITAS THERAPEUTICS US INC. $20.34 09/03/2024 Food and Beverage Undisputed 01/23/2026 1141521525 CMS
CALLIDITAS THERAPEUTICS US INC. $22.53 09/18/2024 Food and Beverage Undisputed 01/23/2026 1141522427 CMS
CALLIDITAS THERAPEUTICS US INC. $26.73 12/04/2024 Food and Beverage Undisputed 01/23/2026 1141528625 CMS
Fresenius USA Marketing, Inc. $21.97 01/30/2024 Food and Beverage Undisputed 01/23/2026 1154197456 CMS
Fresenius USA Marketing, Inc. $23.20 03/26/2024 Food and Beverage Undisputed 01/23/2026 1154197462 CMS
Fresenius USA Marketing, Inc. $20.27 05/14/2024 Food and Beverage Undisputed 01/23/2026 1154197454 CMS
Fresenius USA Marketing, Inc. $22.61 08/13/2024 Food and Beverage Undisputed 01/23/2026 1154197460 CMS
Fresenius USA Marketing, Inc. $22.04 08/22/2024 Food and Beverage Undisputed 01/23/2026 1154197458 CMS
Lilly USA, LLC $18.28 05/20/2024 Food and Beverage Undisputed 01/23/2026 1135405682 CMS
Lilly USA, LLC $21.65 06/24/2024 Food and Beverage Undisputed 01/23/2026 1135375248 CMS
Lilly USA, LLC $24.52 10/07/2024 Food and Beverage Undisputed 01/23/2026 1135392621 CMS
Novartis Pharmaceuticals Corporation $31.38 01/22/2024 Food and Beverage Undisputed 01/23/2026 1087119624 CMS
Novartis Pharmaceuticals Corporation $30.18 08/07/2024 Food and Beverage Undisputed 01/23/2026 1087119628 CMS
Novartis Pharmaceuticals Corporation $26.27 08/23/2024 Food and Beverage Undisputed 01/23/2026 1087119632 CMS
Novartis Pharmaceuticals Corporation $31.12 08/29/2024 Food and Beverage Undisputed 01/23/2026 1087119634 CMS
OPKO Pharmaceuticals, LLC $20.06 02/21/2024 Education Undisputed 01/23/2026 1112847374 CMS
OPKO Pharmaceuticals, LLC $18.63 05/01/2024 Education Undisputed 01/23/2026 1112847376 CMS
OPKO Pharmaceuticals, LLC $20.38 06/06/2024 Education Undisputed 01/23/2026 1112847378 CMS
OPKO Pharmaceuticals, LLC $20.83 12/10/2024 Education Undisputed 01/23/2026 1112847380 CMS
Otsuka America Pharmaceutical, Inc. $25.66 01/08/2024 Food and Beverage Undisputed 01/23/2026 1118944173 CMS
Otsuka America Pharmaceutical, Inc. $20.65 02/07/2024 Food and Beverage Undisputed 01/23/2026 1118944175 CMS
Otsuka America Pharmaceutical, Inc. $25.24 03/19/2024 Food and Beverage Undisputed 01/23/2026 1118944177 CMS
Otsuka America Pharmaceutical, Inc. $15.51 04/18/2024 Food and Beverage Undisputed 01/23/2026 1118944179 CMS
Otsuka America Pharmaceutical, Inc. $25.26 06/04/2024 Food and Beverage Undisputed 01/23/2026 1118944181 CMS
Otsuka America Pharmaceutical, Inc. $24.37 07/15/2024 Food and Beverage Undisputed 01/23/2026 1118944183 CMS
Otsuka America Pharmaceutical, Inc. $17.06 08/19/2024 Food and Beverage Undisputed 01/23/2026 1118944185 CMS
Otsuka America Pharmaceutical, Inc. $16.83 10/02/2024 Food and Beverage Undisputed 01/23/2026 1118944187 CMS
Otsuka America Pharmaceutical, Inc. $22.45 11/12/2024 Food and Beverage Undisputed 01/23/2026 1118944189 CMS
Travere Therapeutics, Inc. $16.89 01/23/2024 Education Undisputed 01/23/2026 1149895644 CMS
Travere Therapeutics, Inc. $30.00 01/23/2024 Food and Beverage Undisputed 01/23/2026 1149895652 CMS
Travere Therapeutics, Inc. $16.89 02/19/2024 Education Undisputed 01/23/2026 1149895648 CMS
Travere Therapeutics, Inc. $30.44 02/19/2024 Food and Beverage Undisputed 01/23/2026 1149895656 CMS
Travere Therapeutics, Inc. $3.08 04/16/2024 Education Undisputed 01/23/2026 1149895641 CMS
Travere Therapeutics, Inc. $2.38 06/24/2024 Education Undisputed 01/23/2026 1149895633 CMS
Travere Therapeutics, Inc. $2.38 08/08/2024 Education Undisputed 01/23/2026 1149895637 CMS
Ultragenyx Pharmaceutical Inc. $20.00 02/29/2024 Food and Beverage Undisputed 01/23/2026 1153286064 CMS
Vifor Pharma, Inc. $15.52 06/11/2024 Food and Beverage Undisputed 01/23/2026 1124042346 CMS
Vifor Pharma, Inc. $19.61 07/17/2024 Food and Beverage Undisputed 01/23/2026 1124049529 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.